Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
Трансмукозное проникновение SARS-CoV-2 через обонятельную слизистую как путь проникновения в центральную нервную систему у лиц с COVID-19
2020-11-30
SCID: 54.1/sqp3vuu2
Discuss with AI
SARS-CoV-2 neurotropismcentral nervous system invasionneural–mucosal interfaceolfactory mucosathromboembolic ischemic infarction
Figures from the paper
Abstract (AI)
Abstract The newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a pandemic respiratory disease presenting with fever, cough, and often pneumonia. Moreover, thromboembolic events throughout the body including the central nervous system (CNS) have been described. Given first indication for viral RNA presence in the brain and cerebrospinal fluid and in light of neurological symptoms in a large majority of COVID-19 patients, SARS-CoV-2-penetrance of the CNS is likely. By precisely investigating and anatomically mapping oro- and pharyngeal regions and brains of 32 patients dying from COVID-19, we not only describe CNS infarction due to cerebral thromboembolism, but also demonstrate SARS-CoV-2 neurotropism. SARS-CoV-2 enters the nervous system via trespassing the neuro-mucosal interface in the olfactory mucosa by exploiting the close vicinity of olfactory mucosal and nervous tissue including delicate olfactory and sensitive nerve endings. Subsequently, SARS-CoV-2 follows defined neuroanatomical structures, penetrating defined neuroanatomical areas, including the primary respiratory and cardiovascular control center in the medulla oblongata.
Key Findings
1
After olfactory entry, SARS-CoV-2 appears to follow neuroanatomical pathways and reach areas including the medulla oblongata’s primary respiratory and cardiovascular control center.
2
SARS-CoV-2 RNA and protein were detected in anatomically distinct regions of the nasopharynx and brain in individuals with COVID-19.
3
SARS-CoV-2 may enter the CNS by crossing the olfactory neural–mucosal interface, exploiting the proximity of olfactory mucosal, endothelial, and nervous tissues.
4
The findings provide evidence of SARS-CoV-2 neurotropism and CNS involvement, including thromboembolic ischemic infarction-associated morphological changes.
Research Object
SARS-CoV-2 infection of the olfactory mucosa, nasopharynx, and central nervous system in individuals with COVID-19
Research Subject
Olfactory transmucosal neuroinvasion, neurotropism, and associated CNS morphological changes including thromboembolic ischemic infarction
Publication Details
Publication Date
2020-11-30
Journal
Publisher
ISSN
Cited by
1458
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai8
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR2020
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China2020
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)2020
A first case of meningitis/encephalitis associated with SARS-Coronavirus-22020
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia2020
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study2020
Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology2020
Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)2020
Cited by16
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records2021
SARS-CoV-2 is associated with changes in brain structure in UK Biobank2022
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms2021
COVID-19–related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters2021
COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital2021
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice2021
Neurovascular injury with complement activation and inflammation in COVID-192022
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-22022
Alzheimer's‐like signaling in brains of COVID‐19 patients2022
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment2021
Neurological complications and infection mechanism of SARS-CoV-22021
SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐192021
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease2021
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathology2023
COVID ‐19 Induces Neuroinflammation and Suppresses Peroxisomes in the Brain2023
Acute viral infection accelerates neurodegeneration in a mouse model of ALS2026